New Delhi, April 1 GLP-1-based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity, but they carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday.Highlighting that...
New Delhi, March 11 The apex drug regulator, CDSCO, has issued an advisory, directing that weight-loss drugs, specifically GLP-1 medications, must only be sold with a prescription from a registered medical practitioner.It cautioned pharmaceutical companies against "directly or indirectly"...
India and Brazil have exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the regulation of pharmaceutical and medical products. In a statement, the Ministry of Health and Family Welfare informed that the MoU was exchanged between India's Central Drugs Standard...
anvisa
bilateral cooperation
brazil
cdsco
dinesh bhatia
health regulation
india
leandro safatle
luiz inácio lula da silva
medical products
memorandum of understanding
narendra modi
new delhi
pharmaceuticalregulation
regulatory affairs
Prayagraj, February 16 The Allahabad High Court has denied bail to two accused in a case linked to the codeine-based cough syrup racket, observing that preparations containing codeine exceeding permissible limits attract the NDPS Act.Justice Ashutosh Srivastava denied relief to Abdul Qadir and...
allahabad high court
bail denial
central government notification
codeine
cough syrup
criminal charges
drug enforcement
illegal drug trafficking
kotwali police station
legal proceedings
methylmorphine
narcotic drugs and psychotropic substances
ndps act
pharmaceuticalregulation
rampur district